Menü
You need to sign in or sign up before continuing.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Could Following Warren Buffett's Advice Leave You With the Wrong Investment Mix?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7835e381-fcae-4834-ba93-4708292dc055.png
Could Following Warren Buffett's Advice Leave You With the Wrong Investment Mix?

Warren Buffett is one of the greatest investors of all time, but those looking to follow the Oracle of Omaha's advice may be surprised to find he doesn't recommend that everyone pick individual

3 Stocks to Avoid This Week
3 Stocks to Avoid This Week

I took a look at three stocks to avoid last week, and I was right. All three stocks declined between 5% and 13%, checking in with an average slide of 9.7% for the holiday-abridged trading week. It

12 Hard-to-Believe Facts About Robinhood
12 Hard-to-Believe Facts About Robinhood

Have you heard of Robinhood? (And no, I don't mean Robin Hood, who stole from the rich to give to the poor.) Have you been wondering what Robinhood is, and what all the fuss about it is? Even if you

AstraZeneca Shows the Risk of Investing in Coronavirus Vaccine Stocks
AstraZeneca Shows the Risk of Investing in Coronavirus Vaccine Stocks

AstraZeneca (NYSE: AZN) has long been considered a leader in the COVID-19 vaccine race. The company is developing its candidate, AZD1222, in collaboration with the University of Oxford. The

2 No-Brainer Stocks to Buy In PharmaPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
2 No-Brainer Stocks to Buy In Pharma

For investors who want the stability and reliable growth of an established business, Amgen (NASDAQ: AMGN) and Biogen (NASDAQ: BIIB) are trusty quick picks. Both are quite profitable, cash-rich, and

Selling Investments at a Profit? This Tax Strategy Could Save You a Ton of Money
Selling Investments at a Profit? This Tax Strategy Could Save You a Ton of Money

Your goal in investing should be to grow your wealth, and holding onto stocks for a long time is generally the best way to do that. But still, you may find yourself wanting to sell a stock at a

7 Must-Knows of Stock Market Crashes and Corrections
7 Must-Knows of Stock Market Crashes and Corrections

For Wall Street and the investment community, 2020 is a year that won't soon be forgotten. The uncertainty and panic caused by the coronavirus disease 2019 (COVID-19) pandemic changed societal

Could Social Security Be Out of Money to Pay Benefits in 2023?
Could Social Security Be Out of Money to Pay Benefits in 2023?

Social Security is not in danger of running out of money under its current funding system. However, President Trump has proposed eliminating payroll taxes, which are currently its primary source of

4 Unstoppable Stocks to Buy With $2,500
4 Unstoppable Stocks to Buy With $2,500

Investing in 2020 should really come with a disclaimer. The past six-plus months have been one of the most volatile periods on record, with the benchmark S&P 500 losing 34% of its value in less than

Merck (Finally) Starts a Clinical Trial of its Coronavirus VaccinePhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Merck (Finally) Starts a Clinical Trial of its Coronavirus Vaccine

Multiple drugmakers are in phase 3 clinical trials for their coronavirus vaccines -- the last stage before potential approval. Meanwhile, Merck (NYSE: MRK) is just now starting the first human study

Gilead Sciences to Acquire Immunomedics for $21 Billion in Cash
Gilead Sciences to Acquire Immunomedics for $21 Billion in Cash

Gilead Sciences' (NASDAQ: GILD) mission to create a better oncology portfolio took a big step forward on Sunday. The company best known for antiviral treatments made Immunomedics (NASDAQ: IMMU) a

Why Carvana's Sales Growth Is About to Skyrocket
Why Carvana's Sales Growth Is About to Skyrocket

You would think a deadly pandemic might put a damper on big-ticket purchases like car sales. And you'd be right. But not if you're talking about used cars -- and especially not if you're talking

MongoDB: 4 Key Themes to WatchPhoto, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
MongoDB: 4 Key Themes to Watch

Since cloud database platform provider MongoDB (NASDAQ: MDB) released its fiscal second-quarter 2021 earnings report on Sept. 2, its shares have experienced an extended swoon, falling 17% to date

Three Income Sources You May Be Shocked to Discover Could Be Taxable
Three Income Sources You May Be Shocked to Discover Could Be Taxable

Most people are well aware that their wages are taxed. But there are some other income sources you may be much more surprised to find Uncle Sam taking a cut of. Here are three of them.

Social

I Never Buy a Stock at IPO, But Snowflake Might Be an Exception
I Never Buy a Stock at IPO, But Snowflake Might Be an Exception

There's a certain allure of finding the next big thing, getting in on the ground floor, and riding it to untold riches. And there are certainly those investors who feel that the best way to make

2 Biotech Stocks with Jaw-Dropping Growth PotentialPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
2 Biotech Stocks with Jaw-Dropping Growth Potential

Biotech stocks have proven time and again to be outstanding growth vehicles for risk-tolerant investors. Underscoring this point, companies like Axsome Therapeutics, Immunomedics, and Novavax have

2 Ways Peloton Will Make Its Equipment More Affordable
2 Ways Peloton Will Make Its Equipment More Affordable

By its own admission, one of the most significant limiting factors for Peloton's (NASDAQ: PTON) growth is the high price of its products. "We've long believed that our price points have represented

Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial: https://investors.biontech.de/media-materials
Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial

Within the next week, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) expect to reach their goal of enrolling 30,000 participants in the phase 2/3 clinical trial testing their coronavirus vaccine

Better Buy: Amazon vs. Best Buy
Better Buy: Amazon vs. Best Buy

2020 has been a landmark year for e-commerce. With shelter-in-place and social distancing orders going into effect, online shopping became a necessity for many households. And many brick-and-mortar

Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical TrialPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Moderna Slowed Enrollment in Its Phase 3 Coronavirus Vaccine Clinical Trial

In the last week, Moderna (NASDAQ: MRNA) substantially slowed enrollment in the phase 3 clinical trial testing its coronavirus vaccine, mRNA-1273. After a slight slowdown last week, the biotech took

Is Cintas Stock a Buy?
Is Cintas Stock a Buy?

There's long been a strong case for arguing that corporate uniform services company Cintas (NASDAQ: CTAS) is a set to be a long-term beneficiary of the COVID-19 pandemic. There's little doubt that

3 Things to Watch in the Stock Market This WeekPhoto, wide shot, wide-angle lens,  Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png
3 Things to Watch in the Stock Market This Week

Stocks dropped last week, as both the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) shed more than 2%. The decline marked a second straight weekly drop following

The 2021 Social Security COLA Will Be Disappointing -- but at Least There'll Be One
The 2021 Social Security COLA Will Be Disappointing -- but at Least There'll Be One

Social Security is vital for the financial survival of tens of millions of retirees. The majority of Social Security recipients rely on the program for most or all of their income. Even for those

Biden's Plan Could Leave You Paying a Higher Tax on an Inheritance
Biden's Plan Could Leave You Paying a Higher Tax on an Inheritance

By 2030, millennials are expected to inherit more than $68 trillion in wealth, according to recent research. If Democratic presidential nominee Joe Biden is elected and gets his wish, the government

A Sputtering Growth Engine Could Ignite an M&A Boom in This SectorPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
A Sputtering Growth Engine Could Ignite an M&A Boom in This Sector

The U.S. oil industry had been growing by leaps and bounds until this year. Output in the country averaged 12.23 million barrels per day (BPD) last year, more than double the production rate of a